4//SEC Filing
Transcept Pharmaceuticals Inc 4
Accession 0001181431-13-040634
CIK 0001178711operating
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 6:11 PM ET
Size
8.0 KB
Accession
0001181431-13-040634
Insider Transaction Report
Form 4
Singh Nikhilesh N
SVP & Chief Scientific Officer
Transactions
- Award
Common Stock Option (right to buy)
2013-07-15+115,000→ 115,000 totalExercise: $2.93Exp: 2023-07-15→ Common Stock (115,000 underlying)
Holdings
- 295(indirect: See footnote)
Common Stock
- 4,787
Common Stock
- 78,206(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]This total includes 2,088 shares purchased on May 31, 2013 under the 2009 Employee Stock Purchase Plan.
- [F2]Shares held directly by the Reporting Person's spouse.
- [F3]Shares held directly by the Singh Family Trust (the "Family Trust") for which Reporting Person's spouse serves as trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Family Trust except to the extent of his pecuniary interest therein.
- [F4]The option vests in forty-eight equal monthly installments beginning on August 15, 2013.
Documents
Issuer
Transcept Pharmaceuticals Inc
CIK 0001178711
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001178711
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 6:11 PM ET
- Size
- 8.0 KB